Glenmark Pharma gains after USFDA approval
Shital Jibhe / 19 Jan 2017
On January 19, Indian markets opened in red at 9 am but at 9:26 am, the Sensex was trading at 27283.23, up by 25.59 points. Meanwhile, Glenmark Pharma opened in green as the company has got a tentative USFDA nod for Olmesartan Medoxomil tablets.
On January 19, Indian markets opened in red at 9 am but at 9:26 am, the Sensex was trading at 27283.23, up by 25.59 points. Meanwhile, Glenmark Pharma opened in green as the company has got a tentative USFDA nod for Olmesartan Medoxomil tablets. These medicines are mostly used for treating high blood pressure.
Thirty day Simple Moving Average (SMA) of the stock stands at 903. In the last one year, the stock has given a return of 13.23 per cent. Currently, the stock company is trading with per-share earnings (P/E) of 31.56. In the last one year, the stock has outperformed Sensex and Healthcare index.
On a three year annualised basis, the stock has given a return of 20.41 per cent. Birla Sun Life Mutual Fund is the top fund house which has invested in the stock of the company.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.